Skip to main content
WELLBIOTEC CO.,LTD logo

WELLBIOTEC CO.,LTD — Investor Relations & Filings

Ticker · 010600 ISIN · KR7010600005 KO Manufacturing
Filings indexed 423 across all filing types
Latest filing 2024-01-10 Major Shareholding Noti…
Country KR South Korea
Listing KO 010600

About WELLBIOTEC CO.,LTD

http://www.wellbiotec.com/?language=eng

WELLBIOTEC CO.,LTD. is a diversified company with operations in several sectors. Its business activities include the development and distribution of biopharmaceutical products, such as specialized medicines, health functional foods, and diagnostic kits. The company is also involved in the electric vehicle (EV) charging business and logistics. Additionally, it manufactures and sells leather products for fashion goods, including shoes and handbags.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically convertible bonds and shareholding percentages) by Sangsangin Savings Bank and its affiliate in Well Biotech Co., Ltd. This type of filing is a mandatory disclosure for significant shareholders crossing ownership thresholds, which falls under the 'Major Shareholding Notification' category.
2024-01-10 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Wellbiotech) regarding a 'Single Sale/Supply Contract' amendment. It details a contract extension for a product supply agreement. Since this is a specific regulatory disclosure regarding a commercial contract amendment and does not fit into categories like M&A, dividends, or financial reports, it is best classified as a general regulatory filing.
2024-01-02 Korean
주권관련사채권의처분결정
Capital/Financing Update Classification · 100% confidence The document is an official regulatory filing from the Korea Exchange (KRX) regarding the 'Disposal of Convertible Bonds' (주권 관련 사채권의 처분결정). It details the financial transaction, the purpose of the disposal (debt repayment and operational funds), and board approval details. This type of corporate disclosure regarding capital structure and financial instruments falls under the 'Capital/Financing Update' category.
2023-12-28 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) and subsequent amendments (정정신고). It details changes to maturity dates, conversion periods, and payment dates for convertible bonds. This falls under the category of capital and financing updates, specifically related to debt instruments and capital structure changes.
2023-12-22 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) and specifically details a correction (정정신고) to the terms of the issuance, such as maturity dates, conversion periods, and payment dates. This falls under capital structure changes and financing updates. According to the provided definitions, documents related to fundraising and financing activities are classified as 'CAP'.
2023-12-22 Korean
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for WellBiotec Co., Ltd. covering the period from January 1, 2023, to September 30, 2023. It contains detailed financial information, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.